Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination therapy for multiple myeloma.

R Alexanian, S Salmon, J Bonnet

    Cancer
    |December 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Insights Into School-Based Physical Activity Implementation Strategies During the COVID-19 Pandemic: A Thematic Analysis.

    Child: care, health and development·2025
    Same author

    [Sleeping Sickness: A Cause of False Positive HIV Rapid Diagnostic Tests].

    Medecine tropicale et sante internationale·2022
    Same author

    Nascent teichoic acids insertion into the cell wall directs the localization and activity of the major pneumococcal autolysin LytA.

    Cell surface (Amsterdam, Netherlands)·2020
    Same author

    Specific and spatial labeling of choline-containing teichoic acids in Streptococcus pneumoniae by click chemistry.

    Chemical communications (Cambridge, England)·2017
    Same author

    Autocatalytic association of proteins by covalent bond formation: a Bio Molecular Welding toolbox derived from a bacterial adhesin.

    Scientific reports·2017
    Same author

    [Comment on the contribution by Erna J. Schilder (1988): Restraining patients? A study of the use of restraints in nursing]].

    Pflege·2012
    Same journal

    Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

    Cancer·2026
    Same journal

    Toward exercise as standard care for older cancer survivors.

    Cancer·2026
    Same journal

    Maintenance therapy in gynecologic malignancies: Current and future state.

    Cancer·2026
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    See all related articles

    Vincristine-containing chemotherapy at 3-week intervals improved multiple myeloma treatment response and survival. Maintenance therapy did not further prolong survival in responding patients.

    Area of Science:

    • Hematology
    • Oncology
    • Clinical Trials

    Background:

    • Multiple myeloma is a hematologic malignancy.
    • Optimizing chemotherapy regimens is crucial for improving patient outcomes.

    Purpose of the Study:

    • To evaluate the efficacy of six different chemotherapy regimens in previously untreated multiple myeloma patients.
    • To assess the impact of maintenance therapy on survival.

    Main Methods:

    • A study involving 462 previously untreated multiple myeloma patients.
    • Comparison of six chemotherapy regimens, including those with and without vincristine, Adriamycin, and alkylating agents.
    • Randomized trial of maintenance therapy with azathioprine-prednisone versus melphalan-cyclophosphamide-carmustine (BCNU)-prednisone in responding patients.

    Related Experiment Videos

    Main Results:

    • Chemotherapy regimens including vincristine and administered at 3-week intervals demonstrated higher response rates and longer survival.
    • No additional benefit was observed from Adriamycin or alkylating agent combinations unless combined with vincristine and short treatment intervals.
    • Maintenance therapy did not significantly prolong survival compared to continued standard therapies or no therapy.

    Conclusions:

    • Vincristine-based chemotherapy with short intervals is effective in multiple myeloma.
    • Maintenance therapy strategies require further investigation for improved survival benefits.
    • Novel therapeutic modalities like immunotherapy and radiotherapy warrant evaluation for tumor reduction.